Localization and pharmacological characterization of somatostatin recognition sites in the human cerebellum

Neuropharmacology

Volumn 35, Issue 6, 1996, Pages 713-723

  Piwko, C ^a   Thoss, V S ^a   Probst, A ^b   Hoyer, D ^a  

^a Preclinical Research   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Autoradiography; Human cerebellum; Radioligand binding; Somatostatin (SRIF somatotropin release inhibiting factor); sst2 SRIF 1, sst1 SRIF 2 receptors

Indexed keywords

CGP 23996; OCTREOTIDE; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR AGONIST; SOMATOSTATIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; CEREBELLUM; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0030175092     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(96)84643-0     Document Type: Article

References (41)

1. Beal M. F., Bird E. D., Langlais P. J. and Martin J. B. (1984) Somatostatin is increased in the nucleus accumbens in Huntington's disease. Neurology 34: 663-666.
2. Bell G. I. and Reisine T. (1993) Molecular biology of somatostatin receptors. Trends Neurosci. 16: 34-38.
3. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem. 72: 248-254.
4. Bucharles C., Vaudry H. and Leroux P. (1994) Pharmacological characterization of somatostatin receptors in rat cerebellar nuclei. Eur. J. Pharmacol. 271: 79-86.
5. Buscail L., Estève J. P., Prats H., Bayard F., Bell G. I., Vaysse N. and Susini C. (1993) Human somatostatin receptor hSSTR-2 may mediate the antiproliferative effect of octreotide. Gastroenterology 104: 816.
6. Canavan A. G. M., Nixon P. D. and Passingham R. E. (1989) Motor learning in monkeys (Macaca fascicularis) with lesions in motor thalamus. Exp. Brain Res. 77: 113-126.
7. Canavan A. G. M., Sprengelmeyer R., Diener H. C. and Hömberg V. (1994) Conditional associative learning is impaired in cerebellar disease in humans. Behav. Neurosci. 108: 475-485.
8. Davies P., Katzman R. and Terry R. D. (1980) Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature 288: 279-280.
9. Epelbaum J., Ruberg M., Moyse E., Javoy-Agid B., Dubois B. and Agid Y. (1983) Somatostatin and dementia in Parkinson's disease. Brain Res. 278: 376-379.
10. Epelbaum J., Dournaud P., Fodor M. and Viollet C. (1994) The neurobiology of somatostatin. Crit. Rev. Neurobiol. 8: 25-44.
11. Feniuk W., Dimech J. and Humphrey P. P. A. (1993) Characterization of somatostatin receptors in guinea pig isolated ileum, vas deferens and right atrium. Br. J. Pharmacol. 110: 154-157.
12. Ferrier I. N., Roberts G. W., Crow T. J., Johnstone E. C., Owens D. G., Lee Y. C., O'Shaughnessy D., Adrian T. E., Polak J. M. and Bloom S. R. (1983) Reduced cholecystokinin-like immunoreactivity and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia. Life Sci. 33: 475-482.
13. Gonzalez B., Leroux P., Lamacz M., Bodenant C., Balazs R. and Vaudry H. (1992) Somatostatin receptors are expressed by immature cerebellar granule cells: Evidence for a direct inhibitory effect of somatostatin on neuroblast activity. Proc. natn. Acad. Sci. U.S.A. 89: 9627-9631.
14. Halsband U. and Passingham R. E. (1985) Premotor cortex and the conditions for movement in monkeys (Macaca fascicularis). Behav. Brain Res. 18: 269-277.
15. 3H]ketanserin. Eur. J. Pharmacol. 18: 13-23.
16. Hoyer D., Lübbert H. and Bruns C. (1994) Molecular pharmacology of somatostatin receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 350: 441-453.
17. Kaupmann K., Bruns C., Hoyer D., Seuwen K. and Lübbert H. (1993) Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain. FEBS Lett. 331: 53-59.
18. Koch B. D., Dorflinger L. J. and Schonbrunn A. (1985) Pertussis toxin blocks both cyclic AMP-mediated and cyclic AMP-independent action of somatostatin. J. biol. Chem. 260: 13138-13145.
19. Laquerrière A., Leroux P., Gonzalez B. J., Bodenant C., Tajot J. and Vaudry H. (1992) Somatostatin receptors in the human cerebellum during development. Brain Res. 573: 251-259.
20. Laquerrière A., Leroux P., Bodenant C., Gonzalez B. J., Tajot J. and Vaudry H. (1994) Quantitative autoradiographic study of somatostatin receptors in the adult human cerebellum. Neuroscience 62: 1147-1154.
21. Leiner H. C., Leiner A. L. and Dow R. S. (1987) Cerebrocerebellar learning loops in apes and human. Ital. J. neurobiol. Sci. 8: 425-436.
22. Leiner H. C., Leiner A. L. and Dow R. S. (1989) Reappraising the cerebellum: What does the hindbrain contribute to the forebrain?. Behav. Neurosci. 103: 998-1008.
23. Leroux P., Bodenant C., Bologna E., Gonzalez B.J. and Vaudry H. (1995) Transient expression of somatostatin receptors in the brain during development. In: Somatostatin and its Receptors (Reichlin S., Ed.), Ciba Foundation Symposium 190, pp. 127-137.
24. Martin J. L., Chesselet M. F., Raynor K., Gonzalez C. and Reisine T. (1991) Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs. Neuroscience 41: 581-593.
25. McKeen E. S., Feniuk W. and Humphrey P. P. A. (1994) Mediation by SRIF-1 receptors of the contractile action of somatostatin in rat isolated distal colon: studies using some novel SRIF analogues. Br. J. Pharmacol. 113: 628-634.
26. Nemeroff C. B., Youngblood W. W., Manberg P. J., Prange A. J. Jr. and Kizer J. S. (1983) Regional brain concentration of neuropeptides in Huntington's chorea and schizophrenia. Science 221: 972-975.
27. Orioli P. J. and Strick P. L. (1989) Cerebellar connections with the motor cortex and the arcuate premotor area: An analysis employing retrograde transneuronal transport of WGA-HPR. J. comp. Neurol. 288: 616-626.
28. Patel Y., Rao K. and Reichlin S. (1977) Somatostatin in human cerebrospinal fluid. New Engl. J. Med. 296: 529-533.
29. 1-5). Endocrinology 135: 2814-2817.
30. Pazos A., Hoyer D. and Palacios J. M. (1984) The binding of serotonergic ligand to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur. J. Pharmacol. 106: 539-546.
31. 2 sites in the rat cerebellum. Naunyn-Schmiedeberg's Arch. Pharmacal. 352: 607-613.
32. Raynor K., Murphy W. A., Coy D. H., Taylor J. E., Moreau J. P., Yasuda K., Bell G. I. and Reisine T. (1993) Cloned somatostatin receptors: Identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Molec. Pharmacol. 43: 838-844.
33. Reichlin S. (1983) Somatostatin. N. Engl. J. Med. 309: 1495-1505, 1556-1563.
34. Reubi J. C. (1985) New specific radioligand for one subpopulation of brain somatostatin receptors. Life Sci. 36: 1829-1836.
35. Reubi J. C. and Maurer R. (1986) Different ionic requirements for somatostatin receptor subpopulation in the brain. Reg. Pep. 14: 301-311.
36. Reubi J. C., Cortès R., Maurer R., Probst A. and Palacios J. M. (1986) Distribution of somatostatin receptors in the human brain, an autoradiographic study. Neuroscience 18: 329-346.
37. Rubinow D. R., Gold P. W., Post R. M. and Ballenger J. C. (1983) CSF somatostatin in affective illness. Archs. gen. Psychiat. 40: 409-412.
38. Schell G. R. and Strick P. L. (1984) The origin of thalamic inputs to the arcuate premotor and supplementary motor area. J. Neurosci. 4: 539-560.
39. Schoeffter P., Pérez J., Langenegger D., Schüpbach E., Lübbert H., Bruns C. and Hoyer D. (1995) Characterization and distribution of somatostatin SS-1 and SRIF-1 binding sites in rat brain: identity with SSTR-2 receptors. Eur. J. Pharmacol., molec. Pharmacol. Sect. 289: 163-173.
40. Sorensen K. V., Christensen S. E., Dupont E., Hansen A. P., Pedersen E. and Orskov H. (1980) Low somatostatin content in cerebrospinal fluid in multiple sclerosis. Acta Neurol. 61: 186-191.
41. Thoss V. S., Piwko C. and Hoyer D. (1996) Somatostatin receptors in the Rhesus monkey brain: localization and pharmacological characterization. Naunyn-Schmiedeberg's Arch. Pharmacol. 353: 648-660.